https://www.business-standard.com/article/companies/bharat-biotech-to-begin-trials-of-intranasal-vaccine-for-covid-in-feb-mar-121010800340_1.html
The Phase-1 trials will be conducted in Saint Louis University’s Vaccine and Treatment Evaluation Unit
Bharat Biotech to begin trials of intranasal vaccine for Covid in Feb-Mar
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Trump’s tariffs are here — countries strike back with countermeasures
- King Charles faces pressure to cut back duties after cancer treatment side effects
- Musk team issued inaccurate USAID firing notices
- More than a dozen migrants die as boats sink off Greece and Türkiye
- Taj Mahal tops ASI ticket earnings for five consecutive years: Govt data
- Fed’s Jefferson says no hurry to adjust rates, need time to assess impact of tariffs
- World girds for trade war in the wake of Trump’s tariff shock
- Scotiabank raises Canada equity rating amid US tariffs
- Fed’s Jefferson: still substantial uncertainty on trade policy, need time to assess
- Fed’s Jefferson favors keeping rates steady as economic uncertainty persists
More from UncategorizedMore posts in Uncategorized »
- Trump’s tariffs are here — countries strike back with countermeasures
- King Charles faces pressure to cut back duties after cancer treatment side effects
- Musk team issued inaccurate USAID firing notices
- More than a dozen migrants die as boats sink off Greece and Türkiye
- Taj Mahal tops ASI ticket earnings for five consecutive years: Govt data
- Fed’s Jefferson says no hurry to adjust rates, need time to assess impact of tariffs
- World girds for trade war in the wake of Trump’s tariff shock
- Scotiabank raises Canada equity rating amid US tariffs
- Fed’s Jefferson: still substantial uncertainty on trade policy, need time to assess
- Fed’s Jefferson favors keeping rates steady as economic uncertainty persists